BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Diagnosis
15 results:

  • 1.
    Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
    Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
    [No Abstract]    [Full Text] [Related]  

  • 2. Infrequent loss of SMARCA4, SMARCA2, and smarcb1 expression in uterine mesenchymal tumors.
    Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Hum Pathol; 2021 Oct; 116():12-21. PubMed ID: 34271067
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Loss of ARID1B and smarcb1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
    Kang EY; Tessier-Cloutier B; Duggan MA; Stewart CJR; Lee CH; Köbel M
    Histopathology; 2021 Aug; 79(2):160-167. PubMed ID: 33432679
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
    Tessier-Cloutier B; Coatham M; Carey M; Nelson GS; Hamilton S; Lum A; Soslow RA; Stewart CJ; Postovit LM; Köbel M; Lee CH
    J Pathol Clin Res; 2021 Mar; 7(2):144-153. PubMed ID: 33125840
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy.
    Libertini M; Hallin M; Thway K; Noujaim J; Benson C; van der Graaf W; Jones RL
    Int J Surg Pathol; 2021 Feb; 29(1):4-20. PubMed ID: 32909482
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Small Cell Carcinoma of the Ovary: Clinicopathologic and Immunohistochemical Analysis of 7 New Cases of a Rare Malignancy.
    Gupta P; Kapatia G; Gupta N; Dey P; Rohilla M; Gupta A; Rai B; Suri V; Rajwanshi A; Srinivasan R
    Int J Surg Pathol; 2021 May; 29(3):236-245. PubMed ID: 32772748
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. uterine Tumor Resembling Ovarian Sex Cord Stromal Tumor (UTROSCT): A Series of 3 Cases With Extensive Rhabdoid Differentiation, Malignant Behavior, and ESR1-NCOA2 Fusions.
    Bennett JA; Lastra RR; Barroeta JE; Parilla M; Galbo F; Wanjari P; Young RH; Krausz T; Oliva E
    Am J Surg Pathol; 2020 Nov; 44(11):1563-1572. PubMed ID: 32675660
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
    Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
    Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. SMARCA4-deficient uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities.
    Kolin DL; Quick CM; Dong F; Fletcher CDM; Stewart CJR; Soma A; Hornick JL; Nucci MR; Howitt BE
    Am J Surg Pathol; 2020 Feb; 44(2):263-270. PubMed ID: 31567195
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Expression of SMARCA4(BRG1) and smarcb1(ini1) in dedifferentiated and undifferentiated endometrial carcinomas and their correlations with clinicopathological features].
    Bi R; Yu L; Tu XY; Ge HJ; Cheng YF; Chang B; Cai X; Jiang WH; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):590-595. PubMed ID: 31422588
    [No Abstract]    [Full Text] [Related]  

  • 11. Multiple primary malignancies associated with a germline smarcb1 pathogenic variant.
    Eelloo JA; Smith MJ; Bowers NL; Ealing J; Hulse P; Wylie JP; Shenjere P; Clarke NW; Soh C; Whitehouse RW; Jones M; Duff C; Freemont A; Gareth Evans D
    Fam Cancer; 2019 Oct; 18(4):445-449. PubMed ID: 31240424
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.
    Tandon B; Hagemann IS; Maluf HM; Pfeifer JD; Al-Kateb H
    Int J Gynecol Pathol; 2017 Nov; 36(6):593-599. PubMed ID: 28177947
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
    Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
    Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. uterine neoplasms composed of rhabdoid cells do not exhibit loss of ini1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
    Al-Hussaini M; Hirschowitz L; McCluggage WG
    Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Aggressive uterine sarcoma with rhabdoid features: diagnosis by peritoneal fluid cytology and absence of ini1 gene mutation.
    Knapik J; Yachnis AT; Ripley D; Biegel JA; Rathor S; Hardt NS; Talerman A; Wilkinson EJ
    Hum Pathol; 2001 Aug; 32(8):884-6. PubMed ID: 11521235
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.